Log In
Print
BCIQ
Print
Print this Print this
 

IT-235 (formerly NKP-2235)

  Manage Alerts
Collapse Summary General Information
Company Intezyne Technologies Inc.
DescriptionOral gallium-based small molecule targeting the endoplasmic reticulum
Molecular Target Endoplasmic reticulum aminopeptidase 1 (ERAP1) (ARTS1) (ERAAP)
Mechanism of ActionGranulocyte colony stimulating factor (G-CSF) receptor (CD114) agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentIND
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$12.4M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today